March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Retinal Damage in Severe Chemical Burn and the Use of Infliximab Therapy
Author Affiliations & Notes
  • Fabiano Cade
    Cornea and Refractive Surgery, Massachusetts Eye & Ear Infirmary, Harvard Medical School, Boston, Massachusetts
    Ophthalmology, Federal Sao Paulo University, Sao Paulo, Brazil
  • Eleftherios Paschalis
    Cornea and Refractive Surgery, Massachusetts Eye & Ear Infirmary, Harvard Medical School, Boston, Massachusetts
  • Caio V. Regatieri
    Ophthalmology, Federal Sao Paulo University, Sao Paulo, Brazil
    Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts
  • Reza Dana
    Cornea and Refractive Surgery, Massachusetts Eye & Ear Infirmary, Harvard Medical School, Boston, Massachusetts
    Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts
  • Claes H. Dohlman
    Cornea and Refractive Surgery, Massachusetts Eye & Ear Infirmary, Harvard Medical School, Boston, Massachusetts
  • Footnotes
    Commercial Relationships  Fabiano Cade, None; Eleftherios Paschalis, None; Caio V. Regatieri, None; Reza Dana, None; Claes H. Dohlman, None
  • Footnotes
    Support  Boston Keratoprosthesis Research Grant
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 6272. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Fabiano Cade, Eleftherios Paschalis, Caio V. Regatieri, Reza Dana, Claes H. Dohlman; Retinal Damage in Severe Chemical Burn and the Use of Infliximab Therapy. Invest. Ophthalmol. Vis. Sci. 2012;53(14):6272.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Severe alkali burns can lead not only to corneal opacity, but also to hard-to-treat glaucoma and/or traction retinal detachment. The aim of this study was to identify the mechanisms of damage to the retina, and its prevention by reducing the inflammatory response after chemical injury.

Methods: : A 20 second burn was performed by applying a 3mm filter paper soaked with 1N NaOH to the central cornea of anesthetized Balb/c mice, followed by continuous irrigation for 15 minutes. The animals were randomly divided into two groups. Group 1 received an intra-peritoneal (i.p.) injection of (anti-TNFα) infliximab, and Group 2 received the same amount of isotype-matched IgG control i.p.. The mice were clinically evaluated at days 1, 3, 5, 7, 10, and 14. Neovascularization of the cornea was measured and compared between groups. TUNEL assay was performed to assess retina damage.

Results: : TUNEL assay showed damage to the ganglion cell layer in Group 2, but not in the infliximab-treated Group 1. Although no statistically significant difference was found at days 1 and 3, subsequently corneal neovascularization invasion into the cornea was significantly less in the infliximab group 1 compared to the control group 2. There was no difference in terms of opacification of the cornea.

Conclusions: : This study demonstrates damage to the ganglion cell layer early after severe alkali burn. Additionally, the data suggest suppression of TNFα can drastically reduce both corneal and retinal damage.

Keywords: inflammation • trauma 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×